Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02016248 · ClinicalTrials.gov registry record · NA
SBRT Boost for Unfavorable Prostate Cancer'
A NA study of Prostate Cancer, sponsored by MemorialCare Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 3
- Study locations
NCT02016248: Recruiting NA study of Prostate Cancer, sponsored by MemorialCare Health System.
NCT02016248 is a NA study of Prostate Cancer that is actively recruiting participants, run by MemorialCare Health System. The registered enrollment target is 150 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02016248, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by MemorialCare Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to find out whether giving a short course of focused radiation called an SBRT "boost" is a safe and effective way to treat prostate cancer. This boost delivers a high dose of radiation to the prostate in a non-invasive way, similar to what is done with high dose rate (HDR) brachytherapy but without using needles. The study looks at how well this treatment controls the cancer, what side effects it may cause, and how it affects patients' quality of life over time.
Primary Outcome
This outcome measures how many participants experience severe (grade 3-5) side effects involving the gastrointestinal or genitourinary systems after receiving the SBRT boost. Toxicities are evaluated using the NCI Common Terminology Criteria for Adverse Events (CTCAE).
Conditions Studied
Interventions
- RADIATION Stereotactic Body Radiotherapy
Study Locations (3)
California
- Orange Coast Memorial Medical Center - Fountain Valley
- Saddleback Memorial Medical Center - Laguna Hills
- Long Beach Memorial Medical Center - Long Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-06 |
| Est. Completion | 2029-06 |
| Phase | NA |
What NCT02016248 shows while recruiting
NCT02016248 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic Body Radiotherapy is the first listed.
NCT02016248 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02016248 about?
NCT02016248 is a clinical study titled "SBRT Boost for Unfavorable Prostate Cancer'". The purpose of this study is to find out whether giving a short course of focused radiation called an SBRT "boost" is a safe and effective way to treat prostate cancer. This boost delivers a high dose of radiation to the prostate in a non-invasive way, similar to what is done with high dose rate (HD...
What is the current status of trial NCT02016248?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2012-06. Estimated completion is 2029-06.
What conditions does trial NCT02016248 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT02016248?
The interventions under investigation include: Stereotactic Body Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT02016248?
This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02016248 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02016248's enrollment target sits among peer trials
150 260th of 735 higher than 464 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02455479 · 150 participants · Phase 1
Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia